---

---

symbols : Glaxf   

save search

---

Geron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directors
Published: 2023-11-28 (Crawled : 21:00) - biospace.com/
UNCY | $1.18 10.28% 9.32% 450K |

Professional, Scientific, and T...

| 104.77% | O: -6.96% H: 7.9% C: 3.35%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 13.92% | O: -0.51% H: 0.96% C: 0.54%
GERN | $3.73 1.08% 1.07% 7.3M |

Health Technology

| 95.29% | O: -1.05% H: 2.65% C: 1.06%
corporation

---

Sarcoma Therapeutics Market 2022-2026 | Patient Assistance Programs to Boost Growth | Technavio
Published: 2022-02-28 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| -1.46% | O: -3.4% H: 7.54% C: 7.54%
CYTR | $0.092 |

Manufacturing

| -80.83% | O: 0.0% H: 0.0% C: -3.12%
NVS | News | $95.12 0.81% 5.43% 2.3M |

Health Technology

| 9.47% | O: 0.5% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| -3.45% | O: -0.21% H: 0.0% C: 0.0%
KPTI | $1.13 -3.42% -4.46% 690K |

Health Technology

| -89.23% | O: 0.1% H: 0.1% C: -1.62%
AGEN A | $5.77 8.66% 7.97% 820K |

Health Technology

| 116.1% | O: -1.31% H: 0.0% C: 0.0%
ADAP | $1.01 3.41% 5.17% 690K |

Health Technology

| -62.45% | O: -1.86% H: 4.92% C: -1.52%
program therapeutics growth

---

Melanoma to be the Most Promising Indication for the PD-1/PDL-1 Inhibitor Therapies in the U.S. and EU-5 Region - Exclusive DeepTech M-A-PTM Analysis by BIS Research
Published: 2022-10-07 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| 36.7% | O: 6.33% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 35.3% | O: 0.63% H: 0.76% C: -0.26%
BMY | $49.14 0.43% 0.12% 6.4M |

Health Technology

| -30.04% | O: 0.14% H: 0.16% C: -0.91%
RCUS 4 | $14.68 0.62% 0.0% 450K |

Health Technology

| -49.41% | O: -1.93% H: 0.53% C: -5.94%
INCY | $51.92 -0.82% -0.83% 1.8M |

Health Technology

| -25.45% | O: -0.72% H: 0.38% C: -1.04%
AGEN A | $5.77 8.66% 7.97% 820K |

Health Technology

| 114.09% | O: -1.78% H: 1.45% C: -2.55%
melanoma research

---

Global Nanobiotechnology Market to Reach $160.3 Billion by 2030
Published: 2023-03-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| 19.34% | O: -3.94% H: 5.51% C: 5.51%
NANX | News | $0.99 2.06% -1.83% 52K |

Manufacturing

| -44.69% | O: 0.56% H: 0.0% C: -4.44%
JNJ | News | $149.12 0.82% 0.3% 7.2M |

Health Technology

| -1.4% | O: 0.41% H: 1.07% C: -0.16%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 21.16% | O: 0.03% H: 1.07% C: -0.03%
AVDL | $17.3 -0.17% 0.06% 820K |

Health Technology

| 87.43% | O: -1.19% H: 0.66% C: -4.61%
ARWR | $23.92 7.12% 6.73% 1.1M |

Health Technology

| -13.74% | O: -0.5% H: 0.33% C: -4.64%
global market

---

RNA- Based Therapeutic Market worth $29.41 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published: 2023-12-05 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| 10.33% | O: -2.6% H: 1.1% C: -1.18%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.28% | O: 0.27% H: 0.12% C: 0.12%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 10.81% | O: -1.01% H: 0.39% C: 0.19%
SLN | $22.59 -0.22% -0.22% 170K |

Health Technology

| 63.28% | O: 1.16% H: 5.02% C: 0.79%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -1.09% | O: -0.5% H: 0.0% C: 0.0%
IONS | $41.07 0.96% 0.97% 710K |

Health Technology

| -20.19% | O: -0.72% H: 0.0% C: -2.13%
BIIB | $194.11 -0.14% -0.15% 930K |

Health Technology

| -16.64% | O: -0.37% H: 0.21% C: -1.05%
ARWR | $23.92 7.12% 6.73% 1.1M |

Health Technology

| -4.05% | O: -1.48% H: 0.67% C: -4.6%
report market

---

Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting
Published: 2022-03-21 (Crawled : 01:00) - globenewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| -0.29% | O: 4.8% H: 4.09% C: 4.09%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| -4.94% | O: 0.96% H: 0.0% C: 0.0%
ZLAB | $14.97 6.4% 6.01% 460K |

Health Technology

| -57.32% | O: 10.34% H: 0.0% C: 0.0%
zejula pos positive results positive results phase 3 primec

---

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| -1.11% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | News | $138.73 1.86% -4.19% 3.6K |

Health Technology

| 14.97% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | News | $9.53 0.32% -1.11% 690K |

Manufacturing

| -11.92% | O: 0.37% H: 0.74% C: 0.28%
TAK | News | $13.36 0.91% -0.52% 1.6M |

Health Technology

| -6.64% | O: 0.14% H: 0.35% C: 0.07%
NVS | News | $95.12 0.81% 5.43% 2.3M |

Health Technology

| -5.73% | O: -0.34% H: 0.23% C: -1.13%
JNJ | News | $149.12 0.82% 0.3% 7.2M |

Health Technology

| -4.78% | O: 0.7% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| -1.17% | O: 1.22% H: 0.07% C: -0.43%
LLY | News | $731.33 0.69% 0.36% 1.7M |

Health Technology

| -0.8% | O: -0.96% H: 1.75% C: 1.75%
BMY | $49.14 0.43% 0.12% 6.4M |

Health Technology

| -1.23% | O: -0.18% H: 0.48% C: -1.91%
ABBV | News | $167.89 0.89% 0.0% 5.6M |

Health Technology

| -2.99% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $14.97 6.4% 6.01% 460K |

Health Technology

| -17.68% | O: -1.15% H: 1.03% C: -1.5%
VRTX | $400.07 1.47% 1.45% 1.3M |

Health Technology

| -5.01% | O: -0.28% H: 0.49% C: -0.32%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| 0.16% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.425 -0.62% -7.02% 9.5K |

Health Technology

| -6.2% | O: -3.1% H: 1.2% C: -0.8%
INCY | $51.92 -0.82% -0.83% 1.8M |

Health Technology

| -10.24% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $194.11 -0.14% -0.15% 930K |

Health Technology

| -20.69% | O: -3.72% H: 0.58% C: -3.82%
AZN | News | $70.13 2.31% 2.24% 4.3M |

Health Technology

| 14.2% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $368.75 2.37% 2.38% 310K |

Health Technology

| -6.1% | O: -2.3% H: 1.65% C: 0.83%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| -7.65% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

---

Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
Published: 2022-08-11 (Crawled : 12:00) - biospace.com/
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| 6.62% | O: -12.81% H: 8.43% C: 5.21%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 5.98% | O: -8.67% H: 2.89% C: 2.14%
FULC | $7.25 5.99% 5.79% 610K |

Health Technology

| -6.57% | O: -10.82% H: 17.27% C: 9.39%
therapeutics update results

---

Oral Biologics & Biosimilars Global Market Report 2022: Drive to Create Insulin Biosimilars Presents Opportunities
Published: 2022-10-14 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 22.68% | O: 6.95% H: 0.0% C: 0.0%
AZNCF | News | $138.73 1.86% -4.19% 3.6K |

Health Technology

| 28.93% | O: 1.95% H: 1.5% C: 1.5%
NVO | News | $125.26 2.08% 0.98% 3.5M |

Health Technology

| 19.49% | O: 0.03% H: 0.35% C: -1.01%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 32.43% | O: 0.59% H: 0.66% C: -0.39%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| 18.93% | O: 2.74% H: 0.0% C: 0.0%
ENTX | $2.05 3.02% 5.24% 170K |

Health Technology

| 135.44% | O: 1.06% H: 0.01% C: -4.53%
AZN | News | $70.13 2.31% 2.24% 4.3M |

Health Technology

| 26.29% | O: 1.22% H: 0.52% C: -2.21%
RVP P | $1.07 0.94% 0.94% 22K |

Health Technology

| -44.56% | O: -1.55% H: 8.42% C: 5.26%
global report insulin market

---

Cancer Gene Therapy Market to Grow at 10.1% through 2032, Amid High Adoption in Breast Cancer Treatment - Future Market Insights, Inc.
Published: 2022-06-27 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| -23.03% | O: 0.47% H: 3.73% C: 3.73%
AZNCF | News | $138.73 1.86% -4.19% 3.6K |

Health Technology

| 7.37% | O: -1.55% H: 4.43% C: 0.03%
NVS | News | $95.12 0.81% 5.43% 2.3M |

Health Technology

| 13.46% | O: 1.86% H: 1.05% C: 0.24%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| -25.68% | O: -0.16% H: 0.61% C: 0.18%
CRNX G | $43.44 1.09% 1.1% 470K |

Health Technology

| 121.52% | O: 0.66% H: 1.22% C: -5.83%
AZN | News | $70.13 2.31% 2.24% 4.3M |

Health Technology

| 5.46% | O: -0.36% H: 1.22% C: 0.38%
AMGN | News | $271.91 1.11% 1.12% 1.4M |

Health Technology

| 10.82% | O: -0.08% H: 0.45% C: -0.13%
ADAP | $1.01 3.41% 5.17% 690K |

Health Technology

| -37.65% | O: 1.85% H: 6.67% C: 3.03%
treatment therapy cancer market

---

Cancer Gene Therapy Market To Reach a Valuation of USD 4047.8 Million by 2028 - Comprehensive Research Report by BrandEssence Market Research
Published: 2022-12-02 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| 14.37% | O: 1.41% H: 0.0% C: -3.13%
AZNCF | News | $138.73 1.86% -4.19% 3.6K |

Health Technology

| 0.35% | O: -0.61% H: 0.08% C: -0.29%
NVS | News | $95.12 0.81% 5.43% 2.3M |

Health Technology

| 5.51% | O: -1.08% H: 1.44% C: 1.28%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 15.87% | O: -0.29% H: 1.55% C: 1.2%
CRNX G | $43.44 1.09% 1.1% 470K |

Health Technology

| 147.24% | O: -0.57% H: 5.9% C: 5.44%
AZN | News | $70.13 2.31% 2.24% 4.3M |

Health Technology

| 2.62% | O: -0.23% H: 0.79% C: 0.43%
ADAP | $1.01 3.41% 5.17% 690K |

Health Technology

| -50.0% | O: -0.99% H: 6.5% C: 3.0%
research report therapy cancer market

---

Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| 30.55% | O: -0.06% H: 0.0% C: 0.0%
AZNCF | News | $138.73 1.86% -4.19% 3.6K |

Health Technology

| 15.13% | O: 6.22% H: 3.13% C: -0.56%
NVS | News | $95.12 0.81% 5.43% 2.3M |

Health Technology

| 14.22% | O: 2.81% H: 0.43% C: -0.2%
JNJ | News | $149.12 0.82% 0.3% 7.2M |

Health Technology

| -14.37% | O: 0.18% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 25.2% | O: 2.59% H: 0.72% C: 0.63%
BMY | $49.14 0.43% 0.12% 6.4M |

Health Technology

| -38.41% | O: 1.22% H: 0.01% C: -1.7%
IOVA M | $11.32 0.09% 0.18% 2M |

Health Technology

| 44.39% | O: 6.12% H: 4.99% C: 4.21%
INO | $10.02 3.51% 3.25% 340K |

Health Technology

| 359.63% | O: 5.5% H: 4.35% C: 3.48%
GILD | $66.95 0.29% 0.28% 3.8M |

Health Technology

| -18.67% | O: 1.43% H: 0.36% C: -1.08%
ATRA | $0.6974 5.51% 4.8% 830K |

Health Technology

| -81.96% | O: 2.58% H: 23.12% C: 20.85%
AZN | News | $70.13 2.31% 2.24% 4.3M |

Health Technology

| 14.87% | O: 7.08% H: 0.84% C: -0.43%
ADAP | $1.01 3.41% 5.17% 690K |

Health Technology

| -51.9% | O: 0.0% H: 7.14% C: 5.71%
covid-19 research global immunotherapy report impact technology market

---

MacroGenics Announces Appointment of William Heiden to Board of Directors
Published: 2022-05-23 (Crawled : 21:00) - biospace.com/
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| -22.89% | O: 3.85% H: 4.48% C: 4.48%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| -8.83% | O: 0.76% H: 0.0% C: 0.0%
MGNX | $15.41 -1.28% -1.3% 770K |

Health Technology

| 287.19% | O: 0.0% H: 3.52% C: -0.5%
ATRA | $0.6974 5.51% 4.8% 830K |

Health Technology

| -86.43% | O: 1.74% H: 1.52% C: -5.14%

---

Global Industry Analysts Predicts the World Medicated Skin Care Products Market to Reach $8 Billion by 2026
Published: 2022-07-04 (Crawled : 09:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.3% 7.2M |

Health Technology

| Email alert Add to watchlist
PBH | $69.8 0.19% 0.0% 350K |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| Email alert Add to watchlist
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| Email alert Add to watchlist
SNOA | $0.1575 5.0% 4.76% 92K |

Health Technology

| Email alert Add to watchlist
care skin market

---

Stem Cells Market To Grow At A CAGR Of 7.9%| Increasing demand for regenerative medicine augment the market growth: Growth Plus Reports
Published: 2021-10-27 (Crawled : 06:00) - prnewswire.com
ALPMF | News | $9.75 6.33% 43.47% 52 |

Health Technology

| -41.48% | O: 2.04% H: 0.0% C: 0.0%
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| 4.32% | O: 0.31% H: 2.03% C: 1.43%
ALPMY | News | $9.53 0.32% -1.11% 690K |

Manufacturing

| -44.66% | O: -0.61% H: 0.73% C: 0.24%
SANA | $7.96 4.6% 4.4% 2.1M |

| -62.56% | O: -0.42% H: 1.42% C: -2.8%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 1.79% | O: 1.07% H: 0.67% C: 0.3%
ema stem cell growth

---

Global mRNA Vaccine Market Research Report 2023-2028: COVID-19 Success Opens New Avenues with with 444 Ongoing Clinical Studies Worldwide
Published: 2023-11-08 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| 17.61% | O: 1.91% H: 0.0% C: 0.0%
VERV | $6.92 4.22% 4.05% 910K |

Professional, Scientific, and T...

| -63.05% | O: 0.37% H: 0.64% C: -10.76%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 16.04% | O: 0.46% H: 0.46% C: -0.23%
MRNA | News S | $104.46 3.01% 2.94% 2.6M |

Health Technology

| 41.81% | O: -0.01% H: 0.03% C: -3.14%
CVAC | $2.53 3.69% 3.37% 600K |

Health Technology

| -54.08% | O: 0.91% H: 1.08% C: -1.44%
BNTX | News | $88.01 1.38% 1.36% 340K |

Health Technology

| -14.03% | O: 0.13% H: 0.08% C: -2.81%
ARCT 4 | $27.06 4.16% 4.03% 330K |

Health Technology

| 38.13% | O: -0.36% H: 0.79% C: -0.61%
covid-19 success report vaccine mrna worldwide ongoing research global market

---

Endocrinology drugs market size to grow by USD 36551.24 Million: Increase in the incidence of endocrine disorders remains key growth driver - Technavio
Published: 2022-12-07 (Crawled : 00:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K |

n/a

| -95.56% | O: 0.0% H: 11.11% C: 2.78%
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| 14.62% | O: 1.92% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.83% | O: 0.5% H: 0.16% C: 0.16%
NVSEF | News | $95.11 5.4% 6.88% 490 |

Health Technology

| 25.42% | O: 0.0% H: 0.0% C: 0.0%
NVS | News | $95.12 0.81% 5.43% 2.3M |

Health Technology

| 3.31% | O: -1.17% H: 1.09% C: 1.01%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 10.06% | O: -1.41% H: 1.75% C: 0.66%
ABT | News | $107.07 -0.2% -0.09% 3.8M |

Health Technology

| 2.16% | O: -0.14% H: 2.32% C: 2.16%
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| -2.49% | O: -1.32% H: 0.0% C: 0.0%
ORMP A | $2.33 2.64% 3.81% 60K |

Health Technology

| -71.96% | O: 0.48% H: 4.55% C: 3.47%
endocrine growth market endocrine disorders

---

Head and Neck Cancer Market worth $ 9.07 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-03-23 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| -1.36% | O: 3.81% H: 0.0% C: -0.44%
AZNCF | News | $138.73 1.86% -4.19% 3.6K |

Health Technology

| 8.45% | O: -4.55% H: 6.28% C: 6.28%
PFE | News A | $26.26 1.0% 0.38% 29M |

Health Technology

| -51.51% | O: -1.94% H: 0.0% C: 0.0%
NVS | News | $95.12 0.81% 5.43% 2.3M |

Health Technology

| 10.37% | O: -0.6% H: 0.0% C: 0.0%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| -6.58% | O: -0.87% H: 0.0% C: 0.0%
BMY | $49.14 0.43% 0.12% 6.4M |

Health Technology

| -30.96% | O: -0.55% H: 0.0% C: 0.0%
MGNX | $15.41 -1.28% -1.3% 770K |

Health Technology

| 68.6% | O: -1.31% H: 3.88% C: -0.67%
KURA | News | $18.19 3.77% 3.79% 2.1M |

Health Technology

| 10.98% | O: -1.34% H: 0.12% C: -2.6%
INCY | $51.92 -0.82% -0.83% 1.8M |

Health Technology

| -33.48% | O: 0.04% H: 0.08% C: -1.26%
AZN | News | $70.13 2.31% 2.24% 4.3M |

Health Technology

| 10.37% | O: -0.31% H: 1.85% C: 1.55%
ADXS | $0.572 12.48% 270 |

Health Technology

| 367.21% | O: -1.64% H: 8.33% C: 0.0%
CVM | $1.51 -3.21% 0.0% 120K |

Health Technology

| -65.37% | O: -0.92% H: 2.31% C: -3.47%
report cancer market

---

Global Nephrotic Syndrome Diagnostics & Therapeutics Market to Grow at 5.6% Annually Through 2028
Published: 2022-09-30 (Crawled : 19:00) - prnewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M |

Health Technology

| Email alert Add to watchlist
AZN | News | $70.13 2.31% 2.24% 4.3M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
AUPH | $5.05 1.2% 1.19% 1.2M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $138.73 1.86% -4.19% 3.6K |

Health Technology

| Email alert Add to watchlist
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| Email alert Add to watchlist
ABT | News | $107.07 -0.2% -0.09% 3.8M |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| Email alert Add to watchlist
DVA | News | $132.52 3.68% -0.12% 540K |

Health Services

| Email alert Add to watchlist
global diagnostics therapeutics market

---

CureVac verlagert Fokus der COVID-19-Impfstoffentwicklung auf mRNA-Technologie der zweiten Generation
Published: 2021-10-12 (Crawled : 12:00) - curevac.com
GLAXF | News | $20.305 0.52% -14.18% 630 |

Health Technology

| 4.1% | O: 3.38% H: 0.0% C: -5.75%
GSK | News | $40.59 2.11% 0.57% 3.5M |

Health Technology

| 6.15% | O: 2.51% H: 0.15% C: -1.43%
CVAC | $2.53 3.69% 3.37% 600K |

Health Technology

| -94.14% | O: -13.04% H: 13.08% C: 9.7%
covid covid-19

---

Gainers vs Losers

74%

26%

Top 10 Gainers

MTTR | News M | $4.8 175.86% 63.6% 71M |

AGBA | $2.5 100.0% 56.6% 200M |

Finance

MLEC | $2.47 76.43% 42.62% 78M |

n/a

NUWE | $0.334 29.96% 40.99% 2.5M |

Manufacturing

EDBL | News | $6.26 66.49% 40.13% 16M |

ATGL | $2.86 46.25% 32.8% 180K |

ZAPP | $0.2175 47.16% 32.05% 16M |

n/a

ONFO | $0.6088 38.68% 27.74% 7.3M |

n/a

VIVK | $1.48 38.32% 27.7% 530K |

Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.7M |

---

Your saved searches

---